National Registry to Study Cardioneuroablation Treatment for Recurrent Vasovagal Syncope and Bradycardia

What this Trial Is About

Researchers are collecting data from multiple centers in France to study cardioneuroablation as a treatment for patients with recurrent vasovagal syncope caused by strong cardioinhibitory effects. This observational registry aims to evaluate success rates, compare different techniques, and support institutions in establishing their own cardioneuroablation programs. Important questions include the procedures success, patient benefit, target sites for ablation, methods for identifying fat pads, and long-term effects. The study focuses on cardioneuroablation, a procedure using radiofrequency ablation to destroy cardiac ganglionated plexi in epicardial fat pads around the atria. Patients with recurrent vasovagal syncope who are scheduled for this procedure will be included. The registry collects data on the recurrence of syncope, efficacy of the procedure, post-ablation symptoms, correlation with ablation sites, patient quality of life, and technical learning curves at participating centers. Participants will be monitored for 12 months to track recurrence of vasovagal syncope and other outcomes. Data collection includes clinical history, procedure details, and follow-up assessments on quality of life and symptoms. The study helps to characterize patient outcomes and improve technical approaches. Participation involves no experimental treatment beyond the scheduled procedure, with data gathered during routine care and follow-up visits.

National Registry of Cardioneuroablation in Recurrent Reflex Syncope